Abediterol clinical trials
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2011
How each study uses abediterol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
6 studies that test it; most in 2011 (2)
| Year | Studies |
|---|---|
| 2011 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses abediterol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Relative Bioavailability Study With Abediterol Administered Via Three Different Inhalation Devices in Healthy Volunteers.TerminatedPhase 1AstraZenecaNCT04199598Written as Abediterol (2.4 μg)
- A Single Dose PD & PK Study With Two Formulations of Abediterol in Patients With AsthmaCompletedPhase 1AstraZenecaNCT02777827Written as Abediterol 0.156 μg
- Single Dose Study to Assess Efficacy, Safety and Tolerability of LAS100977 in Asthmatic Patients.CompletedPhase 2AstraZenecaNCT01425801Written as LAS100977 0.313 μg
- A Study to Evaluate the Disposition of Drug in Body and Safety After Administration of Single Inhaled Doses of Drugs Abediterol and AZD7594 Administered Alone, in Fixed Dose Combination and in Free Combination Using the Dry Powder Inhaler in Healthy Male ParticipantsCompletedPhase 1AstraZenecaNCT02967159Written as Abediterol
- To Assess the Pharmacokinetics, Safety and Tolerability of Abediterol Administered Once Daily for 9 Days, in Patients With Asthma on Inhaled CorticosteroidsCompletedPhase 1AstraZenecaNCT03273127Written as Abediterol
- Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) PopulationCompletedPhase 2AstraZenecaNCT01425814Written as LAS100977
Codes
What other systems call abediterol · ClinicalTrials.gg INT006197
- UNII (FDA) QXA167CM6FABEDITEROLConfirmed FDA, Wikidata
- Wikidata Q4666480abediterolConfirmed FDA, Wikidata
- NCI Thesaurus C132738AbediterolOne source FDA
- DrugBank DB12100One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | QXA167CM6F | ABEDITEROL | Confirmed FDA, Wikidata |
| Wikidata | Q4666480 | abediterol | Confirmed FDA, Wikidata |
| NCI Thesaurus | C132738 | Abediterol | One source FDA |
| DrugBank | DB12100 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.